Login to Your Account



Pharma: Other News To Note


Tuesday, October 29, 2013
• H. Lundbeck A/S, of Valby, Denmark, said the FDA approved Sabril (vigabatrin) as add-on therapy for the treatment of refractory complex partial seizures in children 10 years and older who have inadequately responded to several other treatments and if the possible benefit outweighs the risks of vision loss.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription